Diabetic Med:中国人群研究发现尿糖排泄增多可降低高尿酸血症发病风险

2019-05-07 国际糖尿病编辑部 国际糖尿病

高尿酸血症对健康和疾病的影响不容忽视。 除造成痛风外,高尿酸血症在血脂异常、高血压、糖尿病和肾脏疾病的发生发展中具有重要的作用,因此,明确影响血尿酸水平的因素对上述疾病的早期预防和改善健康转归尤为重要。

高尿酸血症对健康和疾病的影响不容忽视。 除造成痛风外,高尿酸血症在血脂异常、高血压糖尿病和肾脏疾病的发生发展中具有重要的作用,因此,明确影响血尿酸水平的因素对上述疾病的早期预防和改善健康转归尤为重要。

近期东南大学附属中大医院内分泌科、东南大学糖尿病研究所孙子林教授团队研究发现,尿糖排泄增高的人群更倾向于较低的血清尿酸水平,意味着该人群发生高尿酸血症的风险较低。该研究发表在Diabetic Medicine杂志上。

该研究是一项横断面研究,目标人群为新诊断糖尿病人群。根据尿糖排泄量将受试者分为两组,分别为低尿糖排泄组(尿糖排泄量<130mg,n=142,女性68.3%,平均年龄51.02岁)和高尿糖排泄组(尿糖排泄量≥130mg,n=455,女性45.7%,平均年龄49.63岁)。

男性血清尿酸水平超过416μmol/ L或女性血清尿酸水平超过357μmol/ L定义为高尿酸血症。在总人群中,高尿酸血症的患病率为21.4%,其中低尿糖排泄组高尿酸血症的患病率为28.9%,显著高于高尿糖排泄组19.1%(P =0 .019)。无论男性还是女性中,尿糖排泄与血清尿酸水平均呈显著负相关。进一步研究发现,与低尿糖排泄组受试者相比,高尿糖排泄的受试者发生高尿酸血症的风险显著降低(OR=0.47)。此外,控制其他变量(血糖、心率、血压、血脂、年龄等)后,与女性相比,男性高尿酸血症风险显著增加。

点评丨孙子林教授
东南大学附属中大医院

高尿酸血症已成为危害人类健康的全球性公共卫生问题之一。然而,目前影响血清尿酸水平的因素并不清楚。近几年,钠-葡萄糖协同转运蛋白2抑制剂成为治疗糖尿病的热门研究药物,该药通过促进尿糖排泄达到改善血糖的目的。有意思的,是研究发现使用该药的患者血清尿酸水平显著下降。血尿酸水平降低也许和尿糖排泄增加有关。然而,迄今为止,很少有研究关注尿糖排泄与血清尿酸的相关性。

我们的研究发现尿糖排泄与血清尿酸水平呈显著负相关。校正血糖、血压、血脂、年龄、性别等潜在混杂因素后,高尿糖排泄组人群患高尿酸血症风险显著降低。进一步研究分析造成该现象的潜在机制可能与葡萄糖转运蛋白9 (GLUT9)有关。GLUT9主要表达在肾脏和肝脏,除了参与葡萄糖的转运,已经被证实是一种高容量的尿酸盐转运体。肾小管中尿糖含量增多,可能会通过改变GLUT9活性而抑制尿酸的重吸收,导致尿酸排泄增多,最终引起高尿糖排泄患者更倾向于较低的血清尿酸水平。除了有效控制血糖外,促进尿糖排泄可能是降低血清尿酸水平的有效途径,尤其对糖尿病合并高尿酸血症的患者。我们研究的目标人群为既往无糖尿病病史及降糖药物应用史的新诊断糖尿病人群。因此,本研究评估尿糖排泄与血清尿酸水平的关系可能更为准确,因为已经消除降糖药物对尿糖排泄直接或间接的影响。然而,本研究并未检测尿酸排泄量及评估GLUT9表达水平和功能活性。因此,未来的研究在糖尿病人群或动物模型中检测尿酸排泄量,评估GLUT9表达水平和功能活性,进一步明确本研究结果十分有必要。

原始出处:
J. Chen, S.‐H. Qiu, H.‐J. Guo, et al. Increased urinary glucose excretion is associated with a reduced risk of hyperuricaemia. Diabetic Medicine. Mar 2019.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1761116, encodeId=0dd11e611163b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 09:30:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753473, encodeId=ab651e53473ef, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Mon Jul 01 18:30:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743867, encodeId=08f61e43867aa, content=<a href='/topic/show?id=9b185665065' target=_blank style='color:#2F92EE;'>#排泄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56650, encryptionId=9b185665065, topicName=排泄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01c35235377, createdName=维他命, createdTime=Fri Feb 14 22:30:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639109, encodeId=dafb1639109cf, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Nov 22 12:30:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970723, encodeId=9cce19e0723d9, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Apr 04 09:30:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645929, encodeId=97ab1645929cd, content=<a href='/topic/show?id=64644e490b0' target=_blank style='color:#2F92EE;'>#尿糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47490, encryptionId=64644e490b0, topicName=尿糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bce523261420, createdName=liubm563, createdTime=Mon May 13 04:30:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476786, encodeId=67e014e678623, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609745, encodeId=179d1609e45f1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1761116, encodeId=0dd11e611163b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 09:30:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753473, encodeId=ab651e53473ef, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Mon Jul 01 18:30:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743867, encodeId=08f61e43867aa, content=<a href='/topic/show?id=9b185665065' target=_blank style='color:#2F92EE;'>#排泄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56650, encryptionId=9b185665065, topicName=排泄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01c35235377, createdName=维他命, createdTime=Fri Feb 14 22:30:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639109, encodeId=dafb1639109cf, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Nov 22 12:30:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970723, encodeId=9cce19e0723d9, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Apr 04 09:30:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645929, encodeId=97ab1645929cd, content=<a href='/topic/show?id=64644e490b0' target=_blank style='color:#2F92EE;'>#尿糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47490, encryptionId=64644e490b0, topicName=尿糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bce523261420, createdName=liubm563, createdTime=Mon May 13 04:30:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476786, encodeId=67e014e678623, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609745, encodeId=179d1609e45f1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1761116, encodeId=0dd11e611163b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 09:30:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753473, encodeId=ab651e53473ef, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Mon Jul 01 18:30:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743867, encodeId=08f61e43867aa, content=<a href='/topic/show?id=9b185665065' target=_blank style='color:#2F92EE;'>#排泄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56650, encryptionId=9b185665065, topicName=排泄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01c35235377, createdName=维他命, createdTime=Fri Feb 14 22:30:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639109, encodeId=dafb1639109cf, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Nov 22 12:30:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970723, encodeId=9cce19e0723d9, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Apr 04 09:30:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645929, encodeId=97ab1645929cd, content=<a href='/topic/show?id=64644e490b0' target=_blank style='color:#2F92EE;'>#尿糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47490, encryptionId=64644e490b0, topicName=尿糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bce523261420, createdName=liubm563, createdTime=Mon May 13 04:30:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476786, encodeId=67e014e678623, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609745, encodeId=179d1609e45f1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
    2020-02-14 维他命
  4. [GetPortalCommentsPageByObjectIdResponse(id=1761116, encodeId=0dd11e611163b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 09:30:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753473, encodeId=ab651e53473ef, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Mon Jul 01 18:30:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743867, encodeId=08f61e43867aa, content=<a href='/topic/show?id=9b185665065' target=_blank style='color:#2F92EE;'>#排泄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56650, encryptionId=9b185665065, topicName=排泄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01c35235377, createdName=维他命, createdTime=Fri Feb 14 22:30:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639109, encodeId=dafb1639109cf, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Nov 22 12:30:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970723, encodeId=9cce19e0723d9, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Apr 04 09:30:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645929, encodeId=97ab1645929cd, content=<a href='/topic/show?id=64644e490b0' target=_blank style='color:#2F92EE;'>#尿糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47490, encryptionId=64644e490b0, topicName=尿糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bce523261420, createdName=liubm563, createdTime=Mon May 13 04:30:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476786, encodeId=67e014e678623, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609745, encodeId=179d1609e45f1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1761116, encodeId=0dd11e611163b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 09:30:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753473, encodeId=ab651e53473ef, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Mon Jul 01 18:30:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743867, encodeId=08f61e43867aa, content=<a href='/topic/show?id=9b185665065' target=_blank style='color:#2F92EE;'>#排泄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56650, encryptionId=9b185665065, topicName=排泄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01c35235377, createdName=维他命, createdTime=Fri Feb 14 22:30:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639109, encodeId=dafb1639109cf, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Nov 22 12:30:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970723, encodeId=9cce19e0723d9, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Apr 04 09:30:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645929, encodeId=97ab1645929cd, content=<a href='/topic/show?id=64644e490b0' target=_blank style='color:#2F92EE;'>#尿糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47490, encryptionId=64644e490b0, topicName=尿糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bce523261420, createdName=liubm563, createdTime=Mon May 13 04:30:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476786, encodeId=67e014e678623, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609745, encodeId=179d1609e45f1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1761116, encodeId=0dd11e611163b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 09:30:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753473, encodeId=ab651e53473ef, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Mon Jul 01 18:30:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743867, encodeId=08f61e43867aa, content=<a href='/topic/show?id=9b185665065' target=_blank style='color:#2F92EE;'>#排泄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56650, encryptionId=9b185665065, topicName=排泄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01c35235377, createdName=维他命, createdTime=Fri Feb 14 22:30:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639109, encodeId=dafb1639109cf, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Nov 22 12:30:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970723, encodeId=9cce19e0723d9, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Apr 04 09:30:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645929, encodeId=97ab1645929cd, content=<a href='/topic/show?id=64644e490b0' target=_blank style='color:#2F92EE;'>#尿糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47490, encryptionId=64644e490b0, topicName=尿糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bce523261420, createdName=liubm563, createdTime=Mon May 13 04:30:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476786, encodeId=67e014e678623, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609745, encodeId=179d1609e45f1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
    2019-05-13 liubm563
  7. [GetPortalCommentsPageByObjectIdResponse(id=1761116, encodeId=0dd11e611163b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 09:30:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753473, encodeId=ab651e53473ef, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Mon Jul 01 18:30:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743867, encodeId=08f61e43867aa, content=<a href='/topic/show?id=9b185665065' target=_blank style='color:#2F92EE;'>#排泄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56650, encryptionId=9b185665065, topicName=排泄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01c35235377, createdName=维他命, createdTime=Fri Feb 14 22:30:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639109, encodeId=dafb1639109cf, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Nov 22 12:30:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970723, encodeId=9cce19e0723d9, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Apr 04 09:30:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645929, encodeId=97ab1645929cd, content=<a href='/topic/show?id=64644e490b0' target=_blank style='color:#2F92EE;'>#尿糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47490, encryptionId=64644e490b0, topicName=尿糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bce523261420, createdName=liubm563, createdTime=Mon May 13 04:30:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476786, encodeId=67e014e678623, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609745, encodeId=179d1609e45f1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1761116, encodeId=0dd11e611163b, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 05 09:30:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1753473, encodeId=ab651e53473ef, content=<a href='/topic/show?id=6a57e33772b' target=_blank style='color:#2F92EE;'>#研究发现#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73377, encryptionId=6a57e33772b, topicName=研究发现)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1736602208, createdName=hanhaisha2020, createdTime=Mon Jul 01 18:30:00 CST 2019, time=2019-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743867, encodeId=08f61e43867aa, content=<a href='/topic/show?id=9b185665065' target=_blank style='color:#2F92EE;'>#排泄#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56650, encryptionId=9b185665065, topicName=排泄)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01c35235377, createdName=维他命, createdTime=Fri Feb 14 22:30:00 CST 2020, time=2020-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639109, encodeId=dafb1639109cf, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Nov 22 12:30:00 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1970723, encodeId=9cce19e0723d9, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Sat Apr 04 09:30:00 CST 2020, time=2020-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1645929, encodeId=97ab1645929cd, content=<a href='/topic/show?id=64644e490b0' target=_blank style='color:#2F92EE;'>#尿糖#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47490, encryptionId=64644e490b0, topicName=尿糖)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bce523261420, createdName=liubm563, createdTime=Mon May 13 04:30:00 CST 2019, time=2019-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476786, encodeId=67e014e678623, content=<a href='/topic/show?id=f915102342ea' target=_blank style='color:#2F92EE;'>#高尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102342, encryptionId=f915102342ea, topicName=高尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f17331078, createdName=ms622625817193301, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609745, encodeId=179d1609e45f1, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu May 09 13:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=)]

相关资讯

BMJ:不要指责痛风病人“没管住嘴”!虽然这几种食物升高尿酸

都说痛风是富贵病、吃出来的病。有研究发现,红肉、海鲜、喝酒、含糖饮料和与痛风发作有关。

Diabetes Care:尿酸是1型糖尿病患者肾功能、心血管事件和死亡率的独立危险因素

在T1D个体中,较高的UA水平与肾功能、CVE和死亡率下降的风险较高相关,而与其他危险因素无关。该研究结果表明,UA在T1D患者的危险分层中具有很好的作用。

肾功能下降后还能用非布司他降尿酸吗?用什么药来保肾?

一个50岁患者咨询:痛风10年,长期服用止痛药止痛,1年前出现胃溃疡而改用非布司他降尿酸,每天一片40mg,痛风没再发作,但最近体检发现血肌酐升高,问还能不能继续服用非布司他?他的血压也高,已经服用代文治疗,血压达标,但肾功能下降了怎么保肾?

尿酸升高不等于痛风,但是......

尿酸升高不等于痛风,但是尿酸明显升高与痛风发生密切相关。 血尿酸水平超过正常人尿酸正常参考值就是尿酸升高,持续尿酸升高则称为“高尿酸血症”。 它是因嘌呤代谢障碍,使体内尿酸升高的一种状态,无任何临床表现,常常体检时才能发现。引起“高尿酸血症”的主要原因是尿酸的生成增加和或尿酸排出减少。检验医学网

Diabetes Obes Metab:尿酸、肾血流动力学与动脉僵硬度的关系随1型糖尿病史的变化

由此可见,仅在病程较长的T1D老年人中观察到较低GFR、较高动脉硬度和RAAS活化与较高PUA之间的关系。T1D持续时间可以改变PUA、肾血流动力学功能和RAAS激活之间的关联,导致肾血管收缩和缺血。进一步的工作必须确定通过药物降低PUA是否可以预防或逆转长期T1D的有害血液动力学和神经激素后遗症,从而改善患者临床结局。

尿酸高到底是不是吃出来的?

在新浪爱问医生上,一家长焦急的为她儿子咨询: 她儿子22岁,发现血尿酸升高6年,尿酸最高710 μmol/L。孩子不抽烟、不喝酒,平时爱吃肉,自从发现高尿酸后,戒了海鲜,肉吃得也少了,体重从88kg减到了79kg,但血尿酸从没有降到正常,一直维持在510~560 μmol/L之间。家长担心降尿酸药损害肝肾,从不敢让孩子服用降尿酸药。